Eucrates Biomedical Acquisition Corp. Quarterly Liabilities, Current in USD from Q3 2020 to Q4 2022

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: Eucrates Biomedical Acquisition Corp. quarterly Liabilities, Current history and growth rate from Q3 2020 to Q4 2022.
Eucrates Biomedical Acquisition Corp. Liabilities, Current for the quarter ending December 31, 2022 was $65.1K, a 69.4% increase year-over-year.

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2022	$65.1K	+$26.7K	+69.4%	Dec 31, 2022	10-K	2023-04-13
Q3 2022	$120K			Sep 30, 2022	10-Q	2022-11-14
Q2 2022	$202K			Jun 30, 2022	10-Q	2022-08-15
Q1 2022	$197K			Mar 31, 2022	10-Q	2022-05-23
Q4 2021	$38.5K			Dec 31, 2021	10-K	2023-04-13
Q3 2020	$237K			Sep 30, 2020	10-Q	2020-12-07

* An asterisk sign (*) next to the value indicates that the value is likely invalid.